Research Paper Volume 16, Issue 3 pp 2232—2248
Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma
Figure 4. Clinicopathological characteristic of the immune-related eRNAs signature. (A). Differences in the expression of riskscore in various clinicopathological stages; (B) Differences in the proportion of different clinicopathological stages between high and low riskscore groups. (C) KM survival curve showing the survival differences between high and low score groups in different clinicopathological stages.